Related Experiment Videos

Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the

M Sharif1, L Shepstone, C J Elson

  • 1Rheumatology Unit, University Division of Medicine, Bristol Royal Infirmary, Bristol BS2 8HW.

Insights

Serum CRP measured three years prior to assessment, and serum HA at assessment, predict knee osteoarthritis progression. However, neither biomarker reliably predicts individual patient outcomes due to poor specificity and sensitivity.

Area of Science:

  • Biomarkers in Osteoarthritis Research
  • Radiographic Progression Analysis
  • Longitudinal Study Design

Background:

  • Elevated serum C-reactive protein (CRP) and hyaluronate (HA) are linked to long-term knee osteoarthritis (OA) progression.
  • The temporal consistency of these biomarker-progression relationships over time remains unclear.

Purpose of the Study:

  • To investigate if serum CRP and HA concentrations at baseline and three years prior predict knee OA radiological progression over five years.

Main Methods:

  • Knee OA progression was assessed using radiographs from 90 patients over five years.
  • Serum CRP and HA levels were measured at baseline and, for CRP and HA, at three years prior.
  • Logistic regression analysis calculated odds ratios for progression prediction.

Main Results:

  • Serum CRP at three years prior predicted progression (OR 1.90), but not at baseline (OR 1.12).
  • Serum HA at baseline predicted progression (OR 2.32).
  • Significant overlap between groups limited predictive accuracy for individual patients.

Conclusions:

  • Raised serum CRP may indicate events preceding later knee OA radiographic progression.
  • Serum HA concentration at baseline is a predictor of subsequent OA progression.
  • Neither serum CRP nor HA are reliable predictors for individual knee OA progression due to low sensitivity and specificity.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...